SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001103021-20-000148
Filing Date
2020-11-05
Accepted
2020-11-05 16:45:17
Documents
57
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bdsi-20200930.htm   iXBRL 10-Q 1157365
2 EX-31.1 bdsi-20200930x10qex311.htm EX-31.1 8389
3 EX-31.2 bdsi-20200930x10qex312.htm EX-31.2 8416
4 EX-32.1 bdsi-20200930x10qex321.htm EX-32.1 4642
5 EX-32.2 bdsi-20200930x10qex322.htm EX-32.2 4687
  Complete submission text file 0001103021-20-000148.txt   5101835

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bdsi-20200930.xsd EX-101.SCH 28413
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bdsi-20200930_cal.xml EX-101.CAL 65822
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bdsi-20200930_def.xml EX-101.DEF 177029
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bdsi-20200930_lab.xml EX-101.LAB 425959
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bdsi-20200930_pre.xml EX-101.PRE 278397
11 EXTRACTED XBRL INSTANCE DOCUMENT bdsi-20200930_htm.xml XML 873100
Mailing Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612
Business Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612 919 582 9050
BIODELIVERY SCIENCES INTERNATIONAL INC (Filer) CIK: 0001103021 (see all company filings)

IRS No.: 352089858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31361 | Film No.: 201291215
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences